CCKAR - cholecystokinin A receptor Gene

Species: Sus scrofa

Gene Type: protein coding
Gene ID: 100623128

About CCKAR

Primary_assembly 8: 20,188,830-20,199,344 reverse strand.Sscrofa11.1:CM000819.5

This gene has 1 transcript (splice variant), 202 orthologues and 15 paralogues. Biased expression in kidney (RPKM 3.1), mixtures (RPKM .6) and 3 other tissues.

CCKAR Products (5)

mRNA Protein Name
XM_021101082.1 XP_020956741.1 cholecystokinin receptor type A isoform X1
XM_021101084.1 XP_020956743.1 cholecystokinin receptor type A isoform X3
XM_013978565.2 XP_013834019.1 cholecystokinin receptor type A isoform X1
XM_003356886.4 XP_003356934.1 cholecystokinin receptor type A isoform X2
XM_021101083.1 XP_020956742.1 cholecystokinin receptor type A isoform X3

CCKAR Protein Structure

7tm_GPCRs

7tm_GPCRs: cl28897 (53 - 392)

7tm_GPCRs

7tm_GPCRs: cd14964 (55 - 79)

7tm_GPCRs

7tm_GPCRs: cd14964 (88 - 110)

7tm_GPCRs

7tm_GPCRs: cd14964 (126 - 148)

7tm_GPCRs

7tm_GPCRs: cd14964 (171 - 187)

7tm_GPCRs

7tm_GPCRs: cd14964 (218 - 241)

7tm_GPCRs

7tm_GPCRs: cd14964 (323 - 345)

7tm_GPCRs

7tm_GPCRs: cd14964 (360 - 385)

  • 0
  • 100
  • 200
  • 300
  • 400
  • 440 a.a.
Protein Preferred Names Protein Names

cholecystokinin receptor type A

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (4)
Cat. No. Product Name Effect
Purity Phase
HY-128878 Dexloxiglumide Antagonist 98.25% Phase 3
HY-101764 Lintitript Antagonist 99.58% Phase 2
HY-105257 Pranazepide Antagonist 99.81% Phase 2
HY-11077 SR 146131 Agonist 98.23% Phase 1

Pre-clinical Phase

Bioactive Molecules (6)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P1096 A71623 Agonist 99.34% Unkown
HY-B2154 Loxiglumide Antagonist 98.0% Unkown
HY-129810 PD 135158 Antagonist / Unkown
HY-U00363 CHEMBL333994 Antagonist / Unkown
HY-123434 PD-149164 Agonist / Unkown
HY-119127 TP-680 Antagonist / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens CCKAR NCBI NCBI:886